Terray Therapeutics · Series B

Generative AI and ultra-high-throughput chemistry for small-molecule drug discovery

Amount

$120M

Round

Series B

Valuation

—

Announced

Oct 2024

Investors

Lead investor

Bedford Ridge Capital

Participating investors

NVentures (NVIDIA) Maverick Capital Goldcrest Capital Madrona Ventures Two Sigma Ventures XTX Ventures Digitalis Ventures Alexandria Venture Investments